Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | EGFR | P00533 | 3/20 | 0.40 |
| ▸ | PAX8 | Q06710 | 1/20 | 0.35 |
| ▸ | MMP1 | P03956 | 1/20 | 0.32 |
| ▸ | MMP2 | P08253 | 1/20 | 0.32 |
| ▸ | MMP3 | P08254 | 1/20 | 0.32 |
| ▸ | MMP9 | P14780 | 1/20 | 0.32 |
| ▸ | MMP8 | P22894 | 1/20 | 0.32 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.31 |
| ▸ | CHRNB2 | P17787 | 1/20 | 0.31 |
| ▸ | CHRNB4 | P30926 | 1/20 | 0.31 |
| ▸ | CHRNA3 | P32297 | 1/20 | 0.31 |
| ▸ | CHRNA4 | P43681 | 1/20 | 0.31 |
| ▸ | MCL1 | Q07820 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7868646 | 0.83 | NPC1 (0.40) | EGFRPAX8MMP1MMP2MMP3 | |
| SCHEMBL16385528 | 0.83 | CA12 (0.34) | — | |
| SCHEMBL1082715 | 0.78 | TSHR (0.39) | EGFRPAX8KMT2A | |
| SCHEMBL5965047 | 0.78 | EGFR (0.37) | EGFRPAX8 | |
| SCHEMBL2187184 | 0.77 | EGFR (0.42) | EGFRPAX8 | |
| SCHEMBL7936208 | 0.77 | — | — | |
| Ammonia Solution, Strong SCHEMBL5428819 | 0.75 | MMP1 (0.36) | MMP1MMP2MMP3MMP9MMP8 | |
| SCHEMBL21450442 | 0.75 | — | — | |
| N,N-Dimethylethanaminium SCHEMBL446422 | 0.74 | TGFBR1 (0.38) | MMP1MMP2MMP3MMP9MMP8 | |
| SCHEMBL20379699 | 0.73 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2023078413-A1 | FGFR2 INHIBITOR, PREPARATION METHOD THEREFOR, AND PHARMACEUTICAL USE THEREOF | 微境生物医药科技(上海)有限公司 | 2023-05-11 | — | — | WO | disclosed |
| EP-3328950-A1 | HYDROGEL, PRODUCTION, AND MEDICAL DEVICE COMPRISING AN ELECTRODE COATED THEREWITH | Leonh. Lang (AT) | 2018-06-06 | — | — | EP | disclosed |
| WO-2017050424-A1 | HYDROGEL, PRODUCTION, AND MEDICAL DEVICE COMPRISING AN ELECTRODE COATED THEREWITH | LEONH. LANG (AT) | 2017-03-30 | — | — | WO | disclosed |
| EP-2342079-A1 | USE OF COMPOSITE FILMS AS A PACKAGING MATERIAL FOR OXIDATION-SENSITIVE POLYMERS, METHOD FOR PACKAGING OXIDATION-SENSITIVE POLYMERS, AND PACKAGING FORMS CONTAINING SAID COMPOSITE FILMS | BASF SE (DE) | 2011-07-13 | — | — | EP | disclosed |
| WO-2010052088-A1 | USE OF COMPOSITE FILMS AS A PACKAGING MATERIAL FOR OXIDATION-SENSITIVE POLYMERS, METHOD FOR PACKAGING OXIDATION-SENSITIVE POLYMERS, AND PACKAGING FORMS CONTAINING SAID COMPOSITE FILMS | BASF SE (DE) | 2010-05-14 | — | — | WO | disclosed |